Literature DB >> 26297760

Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.

Elizabeth R Wonderlich1, Wen-Chi Wu2, Daniel P Normolle2, Simon M Barratt-Boyes3.   

Abstract

Impaired T cell responses are a defining characteristic of HIV infection, but the extent to which altered mononuclear phagocyte function contributes to this defect is unclear. We show that mononuclear phagocytes enriched from rhesus macaque lymph nodes have suppressed ability to stimulate CD4 T cell proliferation and IFN-γ release after acute SIV infection. When individual populations were isolated, myeloid dendritic cells (mDC) and macrophages but not plasmacytoid DC (pDC) had suppressed capacity to stimulate CD4 T cell proliferation, with macrophage function declining as infection progressed. Macrophages, but not pDC or mDC, had suppressed capacity to induce IFN-γ release from CD4 T cells in acute infection, even after stimulation with virus-encoded TLR7/8 ligand. Changes in expression of costimulatory molecules did not explain loss of function postinfection. Conversely, pDC and mDC had marked loss of IFN-α and IL-12 production, respectively, and macrophages lost production of both cytokines. In T cell cocultures without TLR7/8 ligand, macrophages were the primary source of IL-12, which was profoundly suppressed postinfection and correlated with loss of IFN-γ release by T cells. TLR7/8-stimulated pDC, mDC and macrophages all produced IL-12 in T cell cocultures, which was suppressed in chronic infection. Supplementing IL-12 enhanced mDC-driven IFN-γ release from T cells, and IL-12 and IFN-α together restored function in TLR7/8-activated macrophages. These findings reveal loss of macrophage and mDC T cell-stimulating function in lymph nodes of SIV-infected rhesus macaques associated with diminished IL-12 and IFN-α production that may be a factor in AIDS immunopathogenesis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26297760      PMCID: PMC4575859          DOI: 10.4049/jimmunol.1500683

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Authors:  Jihed Chehimi; Donald E Campbell; Livio Azzoni; Darlene Bacheller; Emmanouil Papasavvas; Ghassen Jerandi; Karam Mounzer; Jay Kostman; Giorgio Trinchieri; Luis J Montaner
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Early T-helper cell defects in HIV infection.

Authors:  G M Shearer; M Clerici
Journal:  AIDS       Date:  1991-03       Impact factor: 4.177

Review 3.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

4.  Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.

Authors:  A A Ansari; A E Mayne; J B Sundstrom; P Bostik; B Grimm; J D Altman; F Villinger
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.

Authors:  Heather Donaghy; Brian Gazzard; Frances Gotch; Steven Patterson
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 6.  T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

Authors:  L Meyaard; H Schuitemaker; F Miedema
Journal:  Immunol Today       Date:  1993-04

7.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Authors:  M Clerici; D R Lucey; J A Berzofsky; L A Pinto; T A Wynn; S P Blatt; M J Dolan; C W Hendrix; S F Wolf; G M Shearer
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

8.  Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals.

Authors:  Michelle A Barron; Naomi Blyveis; Brent E Palmer; Samantha MaWhinney; Cara C Wilson
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

9.  Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo.

Authors:  Marc Dalod; Thais P Salazar-Mather; Lene Malmgaard; Casey Lewis; Carine Asselin-Paturel; Francine Brière; Giorgio Trinchieri; Christine A Biron
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

10.  Impaired interleukin 12 production in human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; A D'Andrea; X Ma; R R MacGregor; J Sennelier; G Trinchieri
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  13 in total

1.  Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.

Authors:  Lamine Alaoui; Gustavo Palomino; Sandy Zurawski; Gerard Zurawski; Sixtine Coindre; Nathalie Dereuddre-Bosquet; Camille Lecuroux; Cecile Goujard; Bruno Vaslin; Christine Bourgeois; Pierre Roques; Roger Le Grand; Olivier Lambotte; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2017-11-13       Impact factor: 9.261

2.  Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity.

Authors:  P S S Rao; Santosh Kumar
Journal:  Alcohol Clin Exp Res       Date:  2016-01       Impact factor: 3.455

Review 3.  Animal models to achieve an HIV cure.

Authors:  Nitasha Kumar; Ann Chahroudi; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

4.  The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.

Authors:  Wen-Rong Yao; Dong Li; Lei Yu; Feng-Jie Wang; Hui Xing; Gui-Bo Yang
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 5.  From dendritic cells to B cells dysfunctions during HIV-1 infection: T follicular helper cells at the crossroads.

Authors:  Nicolas Ruffin; Lylia Hani; Nabila Seddiki
Journal:  Immunology       Date:  2017-03-27       Impact factor: 7.397

6.  Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques.

Authors:  Zachary D Swan; Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Eur J Immunol       Date:  2015-11-24       Impact factor: 5.532

7.  HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway.

Authors:  Qianqian Zhang; Yang Wang; Naicui Zhai; Hongxiao Song; Haijun Li; Yang Yang; Tianyang Li; Xiaolin Guo; Baorong Chi; Junqi Niu; Ian Nicholas Crispe; Lishan Su; Zhengkun Tu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

8.  Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection.

Authors:  Catherine Riou; Rubina Bunjun; Tracey L Müller; Agano Kiravu; Zekarias Ginbot; Tolu Oni; Rene Goliath; Robert J Wilkinson; Wendy A Burgers
Journal:  Tuberculosis (Edinb)       Date:  2016-08-09       Impact factor: 3.131

9.  Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG.

Authors:  Melanie A Gasper; Shameek P Biswas; Bridget S Fisher; Stephanie C Ehnert; David R Sherman; Donald L Sodora
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

Review 10.  Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.

Authors:  Elisabeth Littwitz-Salomon; Ulf Dittmer; Kathrin Sutter
Journal:  Retrovirology       Date:  2016-11-08       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.